Stonebrook Private’s DexCom DXCM Stock Holding History

Stonebrook Private’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,743	Closed	-$521K	–	213
2025 Q3	$521K	Sell	7,743 -447	-5%	-$35.4K	0.11%	130
2025 Q2	$715K	Sell	8,190 -180	-2%	-$14.1K	0.17%	105
2025 Q1	$572K	Buy	8,370 +4,106	+96%	+$335K	0.15%	117
2024 Q4	$332K	Sell	4,264 -638	-13%	-$47.2K	0.09%	135
2024 Q3	$329K	Buy	4,902 +500	+11%	+$41.1K	0.09%	140
2024 Q2	$499K	Buy	4,402 +2,175	+98%	+$275K	0.14%	118
2024 Q1	$309K	Buy	+2,227	New	+$280K	0.09%	158

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stonebrook Private's DXCM Position: Q4 2025 in Review

Stonebrook Private sold out of DexCom (DXCM) in Q4 2025, closing a stake of 7,743 shares — an estimated $521K sold.

Stonebrook Private first reported a position in DXCM in Q1 2024 and held it in 7 quarters. The position peaked at $715K in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Stonebrook Private reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Stonebrook Private sold 7,743 DexCom shares in Q4 2025, an estimated $521K.
Stonebrook Private first reported a position in DexCom in Q1 2024 and held it in 7 quarters.
Stonebrook Private's DexCom position peaked at $715K in Q2 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Stonebrook Private's 13F filing for Q4 2025, filed 11 Feb 2026.